{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:38:12Z","timestamp":1791725892895,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["36093"],"award-info":[{"award-number":["36093"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["143279"],"award-info":[{"award-number":["143279"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["148361"],"award-info":[{"award-number":["148361"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Herpes simplex virus 1 (HSV-1) is responsible for herpes simplex virus encephalitis (HSE), associated with a 70% mortality rate in the absence of treatment. Despite intravenous treatment with acyclovir, mortality remains significant, highlighting the need for new anti-herpetic agents. Herein, we describe a novel neurovirulent recombinant HSV-1 (rHSV-1), expressing the fluorescent tdTomato and Gaussia luciferase (Gluc) enzyme, generated by the Clustered regularly interspaced short palindromic repeats (CRISPR)\u2014CRISPR-associated protein 9 (Cas9) (CRISPR-Cas9) system. The Gluc activity measured in the cell culture supernatant was correlated (P\u2009=\u20090.0001) with infectious particles, allowing in vitro monitoring of viral replication kinetics. A significant correlation was also found between brain viral titers and Gluc activity in plasma (R<jats:sup>2<\/jats:sup>\u2009=\u20090.8510, P\u2009&lt;\u20090.0001) collected from BALB\/c mice infected intranasally with rHSV-1. Furthermore, evaluation of valacyclovir (VACV) treatment of HSE could also be performed by analyzing Gluc activity in mouse plasma samples. Finally, it was also possible to study rHSV-1 dissemination and additionally to estimate brain viral titers by in vivo imaging system (IVIS). The new rHSV-1 with reporter proteins is not only as a powerful tool for in vitro and in vivo antiviral screening, but can also be used for studying different aspects of HSE pathogenesis.<\/jats:p>","DOI":"10.1038\/s41598-021-98047-z","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T10:22:28Z","timestamp":1632219748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis"],"prefix":"10.1038","volume":"11","author":[{"given":"Olus","family":"Uyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier-Luc","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Piret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Venable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Carbonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Corbeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,21]]},"reference":[{"key":"98047_CR1","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","volume":"357","author":"RJ Whitley","year":"2001","unstructured":"Whitley, R. J. & Roizman, B. Herpes simplex virus infections. Lancet 357, 1513\u20131518. https:\/\/doi.org\/10.1016\/S0140-6736(00)04638-9 (2001).","journal-title":"Lancet"},{"key":"98047_CR2","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/molbev\/msu185","volume":"31","author":"JO Wertheim","year":"2014","unstructured":"Wertheim, J. O., Smith, M. D., Smith, D. M., Scheffler, K. & Kosakovsky Pond, S. L. Evolutionary origins of human herpes simplex viruses 1 and 2. Mol. Biol. Evol. 31, 2356\u20132364. https:\/\/doi.org\/10.1093\/molbev\/msu185 (2014).","journal-title":"Mol. Biol. Evol."},{"key":"98047_CR3","unstructured":"Whitley, R., Kimberlin, D. W. & Prober, C. G. in Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (eds A. Arvin et al.) (2007)."},{"key":"98047_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1056\/NEJM198601163140303","volume":"314","author":"RJ Whitley","year":"1986","unstructured":"Whitley, R. J. et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med. 314, 144\u2013149. https:\/\/doi.org\/10.1056\/NEJM198601163140303 (1986).","journal-title":"N. Engl. J. Med."},{"key":"98047_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","volume":"13","author":"MJ Bradshaw","year":"2016","unstructured":"Bradshaw, M. J. & Venkatesan, A. Herpes simplex virus-1 encephalitis in adults: Pathophysiology, diagnosis, and management. Neurotherapeutics 13, 493\u2013508. https:\/\/doi.org\/10.1007\/s13311-016-0433-7 (2016).","journal-title":"Neurotherapeutics"},{"key":"98047_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s13365-014-0302-2","volume":"21","author":"CM Kollias","year":"2015","unstructured":"Kollias, C. M., Huneke, R. B., Wigdahl, B. & Jennings, S. R. Animal models of herpes simplex virus immunity and pathogenesis. J. Neurovirol. 21, 8\u201323. https:\/\/doi.org\/10.1007\/s13365-014-0302-2 (2015).","journal-title":"J. Neurovirol."},{"key":"98047_CR7","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1128\/jvi.77.2.1382-1391.2003","volume":"77","author":"M Tanaka","year":"2003","unstructured":"Tanaka, M., Kagawa, H., Yamanashi, Y., Sata, T. & Kawaguchi, Y. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: Viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J. Virol. 77, 1382\u20131391. https:\/\/doi.org\/10.1128\/jvi.77.2.1382-1391.2003 (2003).","journal-title":"J. Virol."},{"key":"98047_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/1348-0421.12180","volume":"58","author":"T Suenaga","year":"2014","unstructured":"Suenaga, T., Kohyama, M., Hirayasu, K. & Arase, H. Engineering large viral DNA genomes using the CRISPR-Cas9 system. Microbiol. Immunol. 58, 513\u2013522. https:\/\/doi.org\/10.1111\/1348-0421.12180 (2014).","journal-title":"Microbiol. Immunol."},{"key":"98047_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12985-016-0563-x","volume":"13","author":"X Xu","year":"2016","unstructured":"Xu, X., Che, Y. & Li, Q. HSV-1 tegument protein and the development of its genome editing technology. Virol. J. 13, 108. https:\/\/doi.org\/10.1186\/s12985-016-0563-x (2016).","journal-title":"Virol. J."},{"key":"98047_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/v12040466","author":"J Luo","year":"2020","unstructured":"Luo, J. et al. Efficient mutagenesis of Marek\u2019s disease virus-encoded microRNAs using a CRISPR\/Cas9-based gene editing system. Viruses https:\/\/doi.org\/10.3390\/v12040466 (2020).","journal-title":"Viruses"},{"key":"98047_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1462-5822.2004.00378.x","volume":"6","author":"TC Doyle","year":"2004","unstructured":"Doyle, T. C., Burns, S. M. & Contag, C. H. In vivo bioluminescence imaging for integrated studies of infection. Cell. Microbiol. 6, 303\u2013317. https:\/\/doi.org\/10.1111\/j.1462-5822.2004.00378.x (2004).","journal-title":"Cell. Microbiol."},{"key":"98047_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/v8040090","volume":"8","author":"YD Tang","year":"2016","unstructured":"Tang, Y. D. et al. Recombinant pseudorabies virus (PRV) expressing firefly luciferase effectively screened for CRISPR\/Cas9 single guide RNAs and antiviral compounds. Viruses 8, 90. https:\/\/doi.org\/10.3390\/v8040090 (2016).","journal-title":"Viruses"},{"key":"98047_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jviromet.2014.11.009","volume":"213","author":"TA Russell","year":"2015","unstructured":"Russell, T. A., Stefanovic, T. & Tscharke, D. C. Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR\/Cas9 nucleases. J. Virol. Methods 213, 18\u201325. https:\/\/doi.org\/10.1016\/j.jviromet.2014.11.009 (2015).","journal-title":"J. Virol. Methods"},{"key":"98047_CR14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51662","author":"HS Oh","year":"2019","unstructured":"Oh, H. S. et al. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR\/Cas9. Elife https:\/\/doi.org\/10.7554\/eLife.51662 (2019).","journal-title":"Elife"},{"key":"98047_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2144\/000113913","volume":"53","author":"CJ Davidson","year":"2012","unstructured":"Davidson, C. J. et al. Improving the limit of detection for Sanger sequencing: A comparison of methodologies for KRAS variant detection. Biotechniques 53, 182\u2013188. https:\/\/doi.org\/10.2144\/000113913 (2012).","journal-title":"Biotechniques"},{"key":"98047_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2353\/jmoldx.2010.090188","volume":"12","author":"AC Tsiatis","year":"2010","unstructured":"Tsiatis, A. C. et al. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: Diagnostic and clinical implications. J. Mol. Diagn. 12, 425\u2013432. https:\/\/doi.org\/10.2353\/jmoldx.2010.090188 (2010).","journal-title":"J. Mol. Diagn."},{"key":"98047_CR17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/sj.gt.3301469","volume":"8","author":"S Furler","year":"2001","unstructured":"Furler, S., Paterna, J. C., Weibel, M. & Bueler, H. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons. Gene Ther. 8, 864\u2013873. https:\/\/doi.org\/10.1038\/sj.gt.3301469 (2001).","journal-title":"Gene Ther."},{"key":"98047_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nature17664","volume":"533","author":"D Paquet","year":"2016","unstructured":"Paquet, D. et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9. Nature 533, 125\u2013129. https:\/\/doi.org\/10.1038\/nature17664 (2016).","journal-title":"Nature"},{"key":"98047_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/MRA.00993-19","author":"X Jiao","year":"2019","unstructured":"Jiao, X. et al. Complete genome sequence of herpes simplex virus 1 strain McKrae. Microbiol. Resour. Announc. https:\/\/doi.org\/10.1128\/MRA.00993-19 (2019).","journal-title":"Microbiol. Resour. Announc."},{"key":"98047_CR20","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1128\/JVI.64.5.2082-2089.1990","volume":"64","author":"YS Wang","year":"1990","unstructured":"Wang, Y. S. & Hall, J. D. Characterization of a major DNA-binding domain in the herpes simplex virus type 1 DNA-binding protein (ICP8). J. Virol. 64, 2082\u20132089. https:\/\/doi.org\/10.1128\/JVI.64.5.2082-2089.1990 (1990).","journal-title":"J. Virol."},{"key":"98047_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/(sici)1099-1654(199707)7:2<107::aid-rmv191>3.0.co;2-m","volume":"7","author":"FL Homa","year":"1997","unstructured":"Homa, F. L. & Brown, J. C. Capsid assembly and DNA packaging in herpes simplex virus. Rev. Med. Virol. 7, 107\u2013122. https:\/\/doi.org\/10.1002\/(sici)1099-1654(199707)7:2%3c107::aid-rmv191%3e3.0.co;2-m (1997).","journal-title":"Rev. Med. Virol."},{"key":"98047_CR22","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1128\/JVI.80.3.1537-1548.2006","volume":"80","author":"WE Adamson","year":"2006","unstructured":"Adamson, W. E., McNab, D., Preston, V. G. & Rixon, F. J. Mutational analysis of the herpes simplex virus triplex protein VP19C. J. Virol. 80, 1537\u20131548. https:\/\/doi.org\/10.1128\/JVI.80.3.1537-1548.2006 (2006).","journal-title":"J. Virol."},{"key":"98047_CR23","doi-asserted-by":"publisher","first-page":"8560","DOI":"10.1128\/jvi.76.17.8560-8571.2002","volume":"76","author":"DN Everly Jr","year":"2002","unstructured":"Everly, D. N. Jr., Feng, P., Mian, I. S. & Read, G. S. mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: Genetic and biochemical evidence that Vhs is a nuclease. J. Virol. 76, 8560\u20138571. https:\/\/doi.org\/10.1128\/jvi.76.17.8560-8571.2002 (2002).","journal-title":"J. Virol."},{"key":"98047_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1128\/jvi.78.3.1063-1068.2004","volume":"78","author":"JR Smiley","year":"2004","unstructured":"Smiley, J. R. Herpes simplex virus virion host shutoff protein: Immune evasion mediated by a viral RNase?. J. Virol. 78, 1063\u20131068. https:\/\/doi.org\/10.1128\/jvi.78.3.1063-1068.2004 (2004).","journal-title":"J. Virol."},{"key":"98047_CR25","doi-asserted-by":"publisher","first-page":"9117","DOI":"10.1128\/JVI.73.11.9117-9129.1999","volume":"73","author":"DN Everly Jr","year":"1999","unstructured":"Everly, D. N. Jr. & Read, G. S. Site-directed mutagenesis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): Analysis of functional differences between HSV type 1 (HSV-1) and HSV-2 alleles. J. Virol. 73, 9117\u20139129. https:\/\/doi.org\/10.1128\/JVI.73.11.9117-9129.1999 (1999).","journal-title":"J. Virol."},{"key":"98047_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.antiviral.2015.09.007","volume":"123","author":"C Canivet","year":"2015","unstructured":"Canivet, C., Menasria, R., Rheaume, C., Piret, J. & Boivin, G. Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone. Antiviral Res. 123, 105\u2013113. https:\/\/doi.org\/10.1016\/j.antiviral.2015.09.007 (2015).","journal-title":"Antiviral Res."},{"key":"98047_CR27","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00429-014-0733-9","volume":"220","author":"GJ Wojaczynski","year":"2015","unstructured":"Wojaczynski, G. J., Engel, E. A., Steren, K. E., Enquist, L. W. & PatrickCard, J. The neuroinvasive profiles of H129 (herpes simplex virus type 1) recombinants with putative anterograde-only transneuronal spread properties. Brain Struct. Funct. 220, 1395\u20131420. https:\/\/doi.org\/10.1007\/s00429-014-0733-9 (2015).","journal-title":"Brain Struct. Funct."},{"key":"98047_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12033-012-9519-6","volume":"53","author":"SS El-Amouri","year":"2013","unstructured":"El-Amouri, S. S., Cao, P., Miao, C. & Pan, D. Secreted luciferase for in vivo evaluation of systemic protein delivery in mice. Mol. Biotechnol. 53, 63\u201373. https:\/\/doi.org\/10.1007\/s12033-012-9519-6 (2013).","journal-title":"Mol. Biotechnol."},{"key":"98047_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055662","volume":"8","author":"M Aswendt","year":"2013","unstructured":"Aswendt, M., Adamczak, J., Couillard-Despres, S. & Hoehn, M. Boosting bioluminescence neuroimaging: An optimized protocol for brain studies. PLoS ONE 8, e55662. https:\/\/doi.org\/10.1371\/journal.pone.0055662 (2013).","journal-title":"PLoS ONE"},{"key":"98047_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"A Al Shoyaib","year":"2019","unstructured":"Al Shoyaib, A., Archie, S. R. & Karamyan, V. T. intraperitoneal route of drug administration: Should it be used in experimental animal studies?. Pharm. Res. 37, 12. https:\/\/doi.org\/10.1007\/s11095-019-2745-x (2019).","journal-title":"Pharm. Res."},{"key":"98047_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/124595","volume":"2011","author":"C Warden","year":"2011","unstructured":"Warden, C., Tang, Q. & Zhu, H. Herpesvirus BACs: Past, present, and future. J. Biomed. Biotechnol. 2011, 124595. https:\/\/doi.org\/10.1155\/2011\/124595 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"98047_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4149\/av_2013_02_149","volume":"57","author":"M Kudelova","year":"2013","unstructured":"Kudelova, M. et al. Recombinant herpesviruses as tools for the study of herpesvirus biology. Acta Virol. 57, 149\u2013159. https:\/\/doi.org\/10.4149\/av_2013_02_149 (2013).","journal-title":"Acta Virol."},{"key":"98047_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/s0168-9525(00)02015-1","volume":"16","author":"W Brune","year":"2000","unstructured":"Brune, W., Messerle, M. & Koszinowski, U. H. Forward with BACs: new tools for herpesvirus genomics. Trends Genet 16, 254\u2013259. https:\/\/doi.org\/10.1016\/s0168-9525(00)02015-1 (2000).","journal-title":"Trends Genet"},{"key":"98047_CR34","doi-asserted-by":"publisher","first-page":"29903","DOI":"10.1038\/srep29903","volume":"6","author":"AK Brunnemann","year":"2016","unstructured":"Brunnemann, A. K. et al. Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility. Sci. Rep. 6, 29903. https:\/\/doi.org\/10.1038\/srep29903 (2016).","journal-title":"Sci. Rep."},{"key":"98047_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jviromet.2006.03.014","volume":"135","author":"WW Gierasch","year":"2006","unstructured":"Gierasch, W. W. et al. Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J. Virol. Methods 135, 197\u2013206. https:\/\/doi.org\/10.1016\/j.jviromet.2006.03.014 (2006).","journal-title":"J. Virol. Methods"},{"key":"98047_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12896-016-0295-4","volume":"16","author":"AL Richards","year":"2016","unstructured":"Richards, A. L., Sollars, P. J. & Smith, G. A. New tools to convert bacterial artificial chromosomes to a self-excising design and their application to a herpes simplex virus type 1 infectious clone. BMC Biotechnol. 16, 64. https:\/\/doi.org\/10.1186\/s12896-016-0295-4 (2016).","journal-title":"BMC Biotechnol."},{"key":"98047_CR37","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.virol.2006.11.022","volume":"361","author":"JW Balliet","year":"2007","unstructured":"Balliet, J. W., Kushnir, A. S. & Schaffer, P. A. Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: Acute phase replication and reactivation in mice. Virology 361, 372\u2013383. https:\/\/doi.org\/10.1016\/j.virol.2006.11.022 (2007).","journal-title":"Virology"},{"key":"98047_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.37","volume":"4","author":"XH Zhang","year":"2015","unstructured":"Zhang, X. H., Tee, L. Y., Wang, X. G., Huang, Q. S. & Yang, S. H. Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol. Ther. Nucleic Acids 4, e264. https:\/\/doi.org\/10.1038\/mtna.2015.37 (2015).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"98047_CR39","doi-asserted-by":"publisher","first-page":"013","DOI":"10.1093\/ve\/veaa013","volume":"6","author":"CV Kuny","year":"2020","unstructured":"Kuny, C. V., Bowen, C. D., Renner, D. W., Johnston, C. M. & Szpara, M. L. In vitro evolution of herpes simplex virus 1 (HSV-1) reveals selection for syncytia and other minor variants in cell culture. Virus Evol. 6, 013. https:\/\/doi.org\/10.1093\/ve\/veaa013 (2020).","journal-title":"Virus Evol."},{"key":"98047_CR40","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1128\/jvi.74.8.3598-3604.2000","volume":"74","author":"TJ Smith","year":"2000","unstructured":"Smith, T. J., Ackland-Berglund, C. E. & Leib, D. A. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J. Virol. 74, 3598\u20133604. https:\/\/doi.org\/10.1128\/jvi.74.8.3598-3604.2000 (2000).","journal-title":"J. Virol."},{"key":"98047_CR41","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1099\/0022-1317-81-7-1763","volume":"81","author":"T Suzutani","year":"2000","unstructured":"Suzutani, T. et al. The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection. J. Gen. Virol. 81, 1763\u20131771. https:\/\/doi.org\/10.1099\/0022-1317-81-7-1763 (2000).","journal-title":"J. Gen. Virol."},{"key":"98047_CR42","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nri2971","volume":"11","author":"DB McGavern","year":"2011","unstructured":"McGavern, D. B. & Kang, S. S. Illuminating viral infections in the nervous system. Nat. Rev. Immunol. 11, 318\u2013329. https:\/\/doi.org\/10.1038\/nri2971 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"98047_CR43","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.1128\/JVI.00516-14","volume":"88","author":"JM Harkness","year":"2014","unstructured":"Harkness, J. M., Kader, M. & DeLuca, N. A. Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells. J. Virol. 88, 6847\u20136861. https:\/\/doi.org\/10.1128\/JVI.00516-14 (2014).","journal-title":"J. Virol."},{"key":"98047_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008316","volume":"4","author":"E Chung","year":"2009","unstructured":"Chung, E. et al. Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS ONE 4, e8316. https:\/\/doi.org\/10.1371\/journal.pone.0008316 (2009).","journal-title":"PLoS ONE"},{"key":"98047_CR45","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.7150\/jca.15564","volume":"7","author":"F Alessandrini","year":"2016","unstructured":"Alessandrini, F., Ceresa, D., Appolloni, I., Marubbi, D. & Malatesta, P. Noninvasive monitoring of glioma growth in the mouse. J. Cancer 7, 1791\u20131797. https:\/\/doi.org\/10.7150\/jca.15564 (2016).","journal-title":"J. Cancer"},{"key":"98047_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053462","volume":"8","author":"AT Phillips","year":"2013","unstructured":"Phillips, A. T. et al. Bioluminescent imaging and histopathologic characterization of WEEV neuroinvasion in outbred CD-1 mice. PLoS ONE 8, e53462. https:\/\/doi.org\/10.1371\/journal.pone.0053462 (2013).","journal-title":"PLoS ONE"},{"key":"98047_CR47","doi-asserted-by":"publisher","first-page":"12149","DOI":"10.1128\/jvi.76.23.12149-12161.2002","volume":"76","author":"GD Luker","year":"2002","unstructured":"Luker, G. D. et al. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J. Virol. 76, 12149\u201312161. https:\/\/doi.org\/10.1128\/jvi.76.23.12149-12161.2002 (2002).","journal-title":"J. Virol."},{"key":"98047_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00714-17","author":"R Czako","year":"2017","unstructured":"Czako, R. et al. In vivo imaging of influenza virus infection in immunized mice. MBio https:\/\/doi.org\/10.1128\/mBio.00714-17 (2017).","journal-title":"MBio"},{"key":"98047_CR49","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1086\/520094","volume":"196","author":"Y Sergerie","year":"2007","unstructured":"Sergerie, Y., Rivest, S. & Boivin, G. Tumor necrosis factor-alpha and interleukin-1 beta play a critical role in the resistance against lethal herpes simplex virus encephalitis. J. Infect. Dis. 196, 853\u2013860. https:\/\/doi.org\/10.1086\/520094 (2007).","journal-title":"J. Infect. Dis."},{"key":"98047_CR50","doi-asserted-by":"publisher","first-page":"W171","DOI":"10.1093\/nar\/gkz365","volume":"47","author":"K Labun","year":"2019","unstructured":"Labun, K. et al. CHOPCHOP v3: Expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 47, W171\u2013W174. https:\/\/doi.org\/10.1093\/nar\/gkz365 (2019).","journal-title":"Nucleic Acids Res."},{"key":"98047_CR51","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308. https:\/\/doi.org\/10.1038\/nprot.2013.143 (2013).","journal-title":"Nat. Protoc."},{"key":"98047_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/0471250953.bi0203s00","volume":"2","author":"JD Thompson","year":"2002","unstructured":"Thompson, J. D., Gibson, T. J. & Higgins, D. G. Multiple sequence alignment using ClustalW and ClustalX. Curr. Protoc. Bioinform. 2, 23. https:\/\/doi.org\/10.1002\/0471250953.bi0203s00 (2002).","journal-title":"Curr. Protoc. Bioinform."},{"key":"98047_CR53","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fpls.2018.00201","volume":"9","author":"Y Onda","year":"2018","unstructured":"Onda, Y., Takahagi, K., Shimizu, M., Inoue, K. & Mochida, K. Multiplex PCR targeted amplicon sequencing (MTA-Seq): Simple, flexible, and versatile SNP genotyping by highly multiplexed PCR amplicon sequencing. Front. Plant. Sci. 9, 201. https:\/\/doi.org\/10.3389\/fpls.2018.00201 (2018).","journal-title":"Front. Plant. Sci."},{"key":"98047_CR54","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nprot.2017.066","volume":"12","author":"J Quick","year":"2017","unstructured":"Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protoc. 12, 1261\u20131276. https:\/\/doi.org\/10.1038\/nprot.2017.066 (2017).","journal-title":"Nat. Protoc."},{"key":"98047_CR55","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/bib\/bbs012","volume":"14","author":"I Milne","year":"2013","unstructured":"Milne, I. et al. Using Tablet for visual exploration of second-generation sequencing data. Brief Bioinform. 14, 193\u2013202. https:\/\/doi.org\/10.1093\/bib\/bbs012 (2013).","journal-title":"Brief Bioinform."},{"key":"98047_CR56","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1002\/cpbi.102","volume":"70","author":"A Prjibelski","year":"2020","unstructured":"Prjibelski, A., Antipov, D., Meleshko, D., Lapidus, A. & Korobeynikov, A. Using SPAdes de novo assembler. Curr. Protoc. Bioinform. 70, e102. https:\/\/doi.org\/10.1002\/cpbi.102 (2020).","journal-title":"Curr. Protoc. Bioinform."},{"key":"98047_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01428-20","author":"O Uyar","year":"2020","unstructured":"Uyar, O. et al. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis. J Virol https:\/\/doi.org\/10.1128\/JVI.01428-20 (2020).","journal-title":"J Virol"},{"key":"98047_CR58","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1128\/JCM.03274-15","volume":"54","author":"J Piret","year":"2016","unstructured":"Piret, J., Goyette, N. & Boivin, G. Novel method based on real-time cell analysis for drug susceptibility testing of herpes simplex virus and human cytomegalovirus. J. Clin. Microbiol. 54, 2120\u20132127. https:\/\/doi.org\/10.1128\/JCM.03274-15 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"98047_CR59","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1128\/JCM.01275-13","volume":"51","author":"E Drouot","year":"2013","unstructured":"Drouot, E., Piret, J. & Boivin, G. Novel method based on \u201cen passant\u201d mutagenesis coupled with a gaussia luciferase reporter assay for studying the combined effects of human cytomegalovirus mutations. J. Clin. Microbiol. 51, 3216\u20133224. https:\/\/doi.org\/10.1128\/JCM.01275-13 (2013).","journal-title":"J. Clin. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98047-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98047-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:56:51Z","timestamp":1670083011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98047-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,21]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98047"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98047-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,21]]},"assertion":[{"value":"7 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18688"}}